Introduction
Copper, nickel and cobalt metal complexes of heterocyclic thiosemicarbazones, thioureas and 2-substituted pyridines have previously been shown to be potent anti-neoplastic agents in the Ehrlich ascites carcinoma screen [1, 2] . Cytotoxicity was demonstrated against L1210 and Tmolt leukemias, as well as human solid tumor growth, e.g. HeLa, KB nasopharynx, skin, bronchogenic lung carcinomas, bone osteosarcoma and glioma. A mode of action study with copper(II) complexes in L1210 leukemia cells showed that DNA synthesis followed by RNA synthesis was inhibited. The major enzymatic sites of inhibition by the agents include: IMP dehydrogenase, dihydrofolate reductase, DNA polymerase , ribonucleoside reductase, and nucleoside kinase [1, 2] . More important was the observation that DNA strand scission occurred after 24 hr. incubation with the agents. There did not appear to be any evidence of cross linking of the DNA nor did the agents produce intercalation between nucleic bases of DNA. The copper complexes of the heterocyclic thiosemicarbazones, thioureas and 2-substituted pyridines were shown to be L1210 DNA topoisomerase II inhibitors much like the agent fostriecin in that they were competitive blockers of VP-|6's induction of DNA protein linked breaks [3] [4] [5] . The [20] . Carbamyl phosphate synthetase activity was determined with the method ofKalman et al. [21] ; citrulline was determined colorimetrically [22] . 
